These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8882097)

  • 1. Health care worker exposure to aerosolized ribavirin: biological and air monitoring.
    Shults RA; Baron S; Decker J; Deitchman SD; Connor JD
    J Occup Environ Med; 1996 Mar; 38(3):257-63. PubMed ID: 8882097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced environmental exposure to aerosolized ribavirin using a simple containment system.
    Torres A; Krilov LR; Jacobson JM; Kelly KJ; Havens PL
    Pediatr Infect Dis J; 1991 Mar; 10(3):217-21. PubMed ID: 2041670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an in-house-built ribavirin aerosol evacuation system to control incidental employee exposure to ribavirin aerosol.
    Mueller BA; Waldon VK
    J Clin Eng; 1996; 21(1):46-50. PubMed ID: 10154627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposures of health-care workers to ribavirin aerosol: a pharmacokinetic study.
    Linn WS; Gong H; Anderson KR; Clark KW; Shamoo DA
    Arch Environ Health; 1995; 50(6):445-51. PubMed ID: 8572723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin aerosol: methods for reducing employee exposure.
    Arnold SD; Alonso R
    AAOHN J; 1993 Aug; 41(8):382-92. PubMed ID: 8397555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety issues related to the administration of ribavirin.
    Krilov LR
    Pediatr Infect Dis J; 2002 May; 21(5):479-81. PubMed ID: 12150196
    [No Abstract]   [Full Text] [Related]  

  • 7. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
    Bradley JS; Connor JD; Compogiannis LS; Eiger LL
    Antimicrob Agents Chemother; 1990 Apr; 34(4):668-70. PubMed ID: 2344173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational exposures to aerosolized pharmaceuticals and control strategies.
    Decker JA; Seitz TA; Shults RA; Deitchman S; Tucker SP; Belinky BR; Clark NJ
    Scand J Work Environ Health; 1992; 18 Suppl 2():100-2. PubMed ID: 1514061
    [No Abstract]   [Full Text] [Related]  

  • 9. Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.
    Tsai RJ; Boiano JM; Steege AL; Sweeney MH
    Respir Care; 2015 Oct; 60(10):1409-17. PubMed ID: 26152473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational exposure to airborne mercury during gold mining operations near El Callao, Venezuela.
    Drake PL; Rojas M; Reh CM; Mueller CA; Jenkins FM
    Int Arch Occup Environ Health; 2001 Apr; 74(3):206-12. PubMed ID: 11355295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration.
    Kacmarek RM; Kratohvil J
    Respir Care; 1992 Jan; 37(1):37-45. PubMed ID: 10145580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess.
    Ward EM; Sabbioni G; DeBord DG; Teass AW; Brown KK; Talaska GG; Roberts DR; Ruder AM; Streicher RP
    J Natl Cancer Inst; 1996 Aug; 88(15):1046-52. PubMed ID: 8683635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between atmospheric and urinary nickel in workers manufacturing electrical resistances using nickel oxide: role of the bioavailability of nickel.
    Roels H; Van de Voorde R; Vargas VM; Lauwerys R
    Occup Med (Lond); 1993 May; 43(2):95-104. PubMed ID: 8495010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental and occupational exposure to resorcinol in Finland.
    Porras SP; Hartonen M; Ylinen K; Tornaeus J; Tuomi T; Santonen T
    Toxicol Lett; 2018 Dec; 298():125-133. PubMed ID: 29596886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the use of ribavirin aerosols in respiratory syncytial virus infections justified? Clinical and economic evaluation].
    Ventura F; Cheseaux JJ; Cotting J; Guignard JP
    Arch Pediatr; 1998 Feb; 5(2):123-31. PubMed ID: 10223131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial.
    Guerguerian AM; Gauthier M; Lebel MH; Farrell CA; Lacroix J
    Am J Respir Crit Care Med; 1999 Sep; 160(3):829-34. PubMed ID: 10471604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
    Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of metalworking fluid exposure indices for a study of acute respiratory effects.
    Abrams L; Seixas N; Robins T; Burge H; Muilenberg M; Franzblau A
    Appl Occup Environ Hyg; 2000 Jun; 15(6):492-502. PubMed ID: 10853290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma.
    Chaves J; Huen A; Bueso-Ramos C; Safdar A; Vadhan-Raj S
    Clin Infect Dis; 2006 Apr; 42(8):e72-5. PubMed ID: 16575720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
    Smith DW; Frankel LR; Mathers LH; Tang AT; Ariagno RL; Prober CG
    N Engl J Med; 1991 Jul; 325(1):24-9. PubMed ID: 1904551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.